PARIS, 15 mars 2023 /PRNewswire/ — L’Agence Européenne du Médicament vient d’accorder une extension d’indication à l’autorisation de mise sur le marché de WAKIX® (pitolisant), désormais indiqué dans le traitement de la narcolepsie de l’enfant de plus de 6 ans, avec ou sans cataplexie. La…

PARIS, March 15, 2023 /PRNewswire/ — The European Medicines Agency has just granted an extension of the indication for the marketing authorisation for WAKIX® (pitolisant), which is now indicated for the treatment of narcolepsy in children from the age of 6 years, with or without…

NEW YORK, March 15, 2023 /PRNewswire/ — The global ethylene glycol market size is estimated to grow by 9,171.73 thousand t from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 4.83% during the forecast period. The market is driven by the increase in…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.